• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>International journal of molecular imaging >[F18]Fluoro-2-Deoxy-D-Glucose Incorporation by MCF-7 Breast TumourCellsIn VitroIs Modulated by Treatment with Tamoxifen,Doxorubicin, and Docetaxel: Relationship to Chemotherapy-InducedChanges in ATP Content, Hexokinase Activity, and Glucose Transport
【24h】

[F18]Fluoro-2-Deoxy-D-Glucose Incorporation by MCF-7 Breast TumourCellsIn VitroIs Modulated by Treatment with Tamoxifen,Doxorubicin, and Docetaxel: Relationship to Chemotherapy-InducedChanges in ATP Content, Hexokinase Activity, and Glucose Transport

机译：[F18]由Tamoxifen，阿霉素和多西他赛治疗可通过MCF-7乳腺肿瘤细胞体外掺入氟-2-脱氧-D-葡萄糖：与化疗引起的ATP含量，己糖激酶活性和葡萄糖转运变化的关系

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Breast tumours responding to chemotherapy exhibit decreased [F18]fluoro-2-deoxy-D-glucose ([F18]FDG) incorporation. Underlying mechanisms of these changes is poorly understood. Here, in MCF-7 cells, responding to chemotherapy drugs commonly utilised in the treatment of breast cancer, [F18]FDG incorporation and several pivotal factors associated with [F18]FDG incorporation investigated.Methods. IC50 and subclinical doxorubicin, docetaxel, and tamoxifen doses determined using MTT assay. [F18]FDG incorporation by cells treated with IC50 drug doses for 48 hours and 72 hours were determined and FDG dephosphorylation estimated by measuring loss of 18F from [F18]FDG-preincubated cells (pulse-chase). Glucose transport determined by measuring initial uptake rate of non-metabolised glucose analogue omethylglucose; hexokinase activity and ATP content measured in cell homogenates; Cell cycle distribution determined using flow cytometry of propidium iodide stained nuclei.Results. [F18]FDG incorporation and ATP content decreased in cells after 72 hours treatment with IC50 doses of tamoxifen, doxorubicin, and docetaxel compared with untreated controls. Decreased glucose transport and/or hexokinase activity accompanied decreased [F18]FDG incorporation by MCF-7 cells treated with tamoxifen or doxorubicin but not docetaxel.Conclusions. Tumour cell [F18]FDG incorporation along with ATP content decreased by treatment with tamoxifen, doxorubicin and docetaxel paralleling clinical observations for solid tumours. Effect of each treatment on glucose transport and hexokinase activity was chemotherapy-drug dependent.
机译：对化学疗法有反应的乳腺癌肿瘤表现出减少的[F18]氟-2-脱氧-D-葡萄糖（[F18] FDG）掺入。这些变化的潜在机制了解甚少。在这里，在MCF-7细胞中，对通常用于治疗乳腺癌的化学疗法的反应，[F18] FDG的掺入以及与[F18] FDG掺入有关的几个关键因素进行了研究。使用MTT分析法测定IC50和亚临床阿霉素，多西他赛和他莫昔芬的剂量。确定通过IC50药物剂量处理48小时和72小时的细胞中[F18] FDG的掺入，并通过测量[F18] FDG预孵育的细胞（脉冲追踪）中18F的损失来估算FDG的去磷酸化。通过测量未代谢的葡萄糖类似物邻甲基葡萄糖的初始摄取率来确定葡萄糖转运;细胞匀浆中己糖激酶活性和ATP含量;使用碘化丙啶染色的核的流式细胞术确定细胞周期分布。与未处理的对照组相比，用IC50剂量的他莫昔芬，阿霉素和多西他赛处理72小时后，细胞中[F18] FDG的掺入和ATP含量降低。用他莫昔芬或阿霉素而非多西紫杉醇处理的MCF-7细胞伴随的葡萄糖转运和/或己糖激酶活性降低而导致[F18] FDG掺入减少。通过他莫昔芬，阿霉素和多西他赛治疗可降低肿瘤细胞[F18] FDG的掺入以及ATP含量，与实体瘤的临床观察结果相似。每种治疗对葡萄糖转运和己糖激酶活性的影响是化疗药物依赖性的。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号